2026: Discover the Breakthrough NV01-A02 Autism Treatment Revolutionizing Lives
AI 요약 정보
- NeuroVenti reports Phase 2 gains in social and behavior measures
- NV01-A02 targets serotonin and dopamine systems
- NeuroVenti aims for global exports and Phase 3 trials next year